CCO Treatment Updates
Novel Approaches in Frontline Multiple Myeloma Therapy: Understanding the Options and Implications for Transplantation
Module
Advances in the Frontline Treatment of Multiple Myeloma
|
|
|
Amitabha Mazumder, MD, reviews novel agents and combinations for the frontline clinical management of patients with multiple myeloma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain disease staging in the clinical management of patients with multiple myeloma
- Discuss the use of bortezomib, both as monotherapy and in combination regimens, in the treatment of multiple myeloma
- Describe the role of stem cell transplantation in the clinical management of patients with multiple myeloma
- Articulate differences in treatment options and approaches for elderly vs younger patients with multiple myeloma
|
Interactive Case Challenges
Clinical Management of a 59-Year-Old Male Patient With Multiple Myeloma and Renal Dysfunction
|
|
|
Join Jean-Luc Harousseau, MD, as he discusses the clinical management of a middle-aged male patient with multiple myeloma and renal dysfunction.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe induction treatment options prior to autologous stem cell transplantation
- Discuss first-line treatment options for patients with renal insufficiency
- Relate the effective management of bortezomib-induced peripheral neuropathy
- Summarize options for therapy for multiple myeloma patients following autologous stem cell transplantation
|
Management of a Transplantation-Eligible 58-Year-Old Male With Newly Diagnosed Multiple Myeloma
|
|
|
In this Interactive Case Challenge, William I. Bensinger, MD, explores therapeutic options for newly diagnosed myeloma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify optimal induction therapies for patients with newly diagnosed multiple myeloma
- Describe therapeutic options for a patient with multiple myeloma who has achieved a major response but not a complete response to induction therapy
- Discuss the implications of achieving a complete response on novel therapy for treatment of newly diagnosed multiple myeloma
|
Treatment of Newly Diagnosed Multiple Myeloma in a 78-Year-Old Woman
|
|
|
In this Interactive Case Challenge, Kenneth Anderson, MD, reviews current clinical data and explores treatment options for an elderly patient with newly diagnosed multiple myeloma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify optimal frontline treatment options for elderly patients with newly diagnosed multiple myeloma
- Describe therapeutic options for elderly patients with multiple myeloma who have achieved a complete response to induction therapy
- Discuss clinical studies relating to the treatment of relapsed multiple myeloma in elderly patients
|
CCO Slideset
Advances in the Frontline Treatment of Multiple Myeloma
 |
|
Amitabha Mazumder, MD, reviews the integration of novel agents into the frontline treatment of ASCT-eligible and ASCT-ineligible multiple myeloma patients.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.50 MB
|
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
This educational program has been supported by
Educational grants support only the CME-certified components of this program.
|
|